https://www.solenomedicalaffairs.com/wp-content/uploads/2025/01/Soleno_MA_Logo.png
0
0
Admin
https://www.solenomedicalaffairs.com/wp-content/uploads/2025/01/Soleno_MA_Logo.png
Admin2025-05-13 09:00:132025-06-25 19:05:44European Congress of Endocrinology (ECE) and the European Society for Paediatric Endocrinology (ESPE), 2025
https://www.solenomedicalaffairs.com/wp-content/uploads/2025/01/Soleno_MA_Logo.png
0
0
Admin
https://www.solenomedicalaffairs.com/wp-content/uploads/2025/01/Soleno_MA_Logo.png
Admin2025-04-01 20:00:092025-08-04 12:37:15Capturing the Burden of Prader-Willi Syndrome on Patients and the Healthcare System: A Real-World Analysis of United States Claims Data.
https://www.solenomedicalaffairs.com/wp-content/uploads/2025/01/Soleno_MA_Logo.png
0
0
Admin
https://www.solenomedicalaffairs.com/wp-content/uploads/2025/01/Soleno_MA_Logo.png
Admin2025-03-14 17:16:522025-05-17 17:43:24Resuming Diazoxide Choline Extended-Release (DCCR) after 16-week Randomized Withdrawal is Associated with Significant Improvements in Hyperphagia and Behavioral Symptoms in PWS (Study C614)
https://www.solenomedicalaffairs.com/wp-content/uploads/2025/01/Soleno_MA_Logo.png
0
0
Admin
https://www.solenomedicalaffairs.com/wp-content/uploads/2025/01/Soleno_MA_Logo.png
Admin2025-03-14 17:16:082025-05-19 17:47:56Long-term Administration of Diazoxide Choline Extended-Release (DCCR) Tablets in People with Prader-Willi Syndrome: Changes in Lean Body Mass and Lean Mass Index
https://www.solenomedicalaffairs.com/wp-content/uploads/2025/01/Soleno_MA_Logo.png
0
0
Admin
https://www.solenomedicalaffairs.com/wp-content/uploads/2025/01/Soleno_MA_Logo.png
Admin2025-03-14 17:13:412025-05-17 16:40:00Pediatric Endocrine Society, 2025
https://www.solenomedicalaffairs.com/wp-content/uploads/2025/01/Soleno_MA_Logo.png
0
0
Admin
https://www.solenomedicalaffairs.com/wp-content/uploads/2025/01/Soleno_MA_Logo.png
Admin2025-03-14 17:03:512026-02-18 08:44:49Academy of Managed Care Pharmacy, 2025
https://www.solenomedicalaffairs.com/wp-content/uploads/2025/01/Soleno_MA_Logo.png
0
0
Admin
https://www.solenomedicalaffairs.com/wp-content/uploads/2025/01/Soleno_MA_Logo.png
Admin2025-03-11 10:39:142025-05-17 16:40:56Design of a Randomized Withdrawal Period Following Long-Term Administration of Diazoxide Choline Extended-Release Tablets to People with Prader-Willi Syndrome
https://www.solenomedicalaffairs.com/wp-content/uploads/2025/01/Soleno_MA_Logo.png
0
0
Admin
https://www.solenomedicalaffairs.com/wp-content/uploads/2025/01/Soleno_MA_Logo.png
Admin2025-03-11 10:33:422025-05-17 16:41:12Withdrawal of Diazoxide Choline Extended-Release (DCCR) Tablets Worsens Hyperphagia and Increases Weight and BMI in a 16-Week Double-Blind, Placebo-Controlled, Randomized Withdrawal Period in Patients With Prader-Willi Syndrome
https://www.solenomedicalaffairs.com/wp-content/uploads/2025/01/Soleno_MA_Logo.png
0
0
Admin
https://www.solenomedicalaffairs.com/wp-content/uploads/2025/01/Soleno_MA_Logo.png
Admin2025-03-11 10:29:262025-05-17 16:41:28Long-Term Safety of Diazoxide Choline Extended-Release (DCCR) Tablets in Participants with Prader-Willi Syndrome from the Completed C601 Randomized Double-Blind Placebo-Controlled Study (DESTINY PWS) and C602 Open Label Extension (OLE) Study
https://www.solenomedicalaffairs.com/wp-content/uploads/2025/01/Soleno_MA_Logo.png
0
0
Admin
https://www.solenomedicalaffairs.com/wp-content/uploads/2025/01/Soleno_MA_Logo.png
Admin2025-03-11 10:26:412025-05-17 16:41:47Relaxation of Food Control Parameters Based on Improvements in the Food Safe Zone Questionnaire Occurs with Reduction of Hyperphagia in Clinical Trials of Diazoxide Choline Extended Release (DCCR) in Participants with Prader-Willi Syndrome.
